Riassunto
La storia naturale delle neoplasie solide inizia da una malattia confinata in una specifica area anatomica. Nelle neoplasie localizzate, la chirurgia rappresenta il fondamento terapeutico. La radioterapia può svolgere un ruolo curativo in situazioni specifiche, ma in generale, insieme alla chemioterapia, rimane un trattamento adiuvante.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Bibliografia
Ensminger WD (2001) Intraarterial therapy. In: Perry CM (ed) The chemotherapy source book, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 163–174
Rossi CR, Foletto M, Pilati P et al (2002) Isolated limb perfusion in locally advanced cutaneous melanoma. Semin Oncol 29:400–409
Markman M (1998) Intraperitoneal therapy in ovarian cancer. Semin Oncol 25:356–360
Alexander HR, Kemeny NE, Lawrence TS (2005) Metastatic cancer to the liver. In: De Vita VT, Hellmann S, Rosenberg SA (eds) Cancer principles & practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 2352–2367
Lise M, Pilati P, Da Pian P et al (2003) Treatment options for liver metastases from colorectal cancer. J Exp Clin Cancer Res 22:149–156
Kemeny N (2007) Presurgical chemotherapy in patients being considered for liver resection. Oncologist 12:825–839
Vadeyar HJ (2007) Current therapeutic options for colorectal liver metastases. Indian J Gastroenterol 26:26–29
Rossi CR, Foletto M, Pilati P et al (2002) Isolated limb perfusion in locally advanced cutaneous melanoma. Semin Oncol 29:400–409
Rossi CR, Foletto M, Mocellin S (2004) Hyperthermic isolated limb perfusion with low—dose tumor necrosis factor-alpha and melphalan for bulky in-transit melanoma metastases. Ann Surg Oncol 11:173–177
Di Filippo F, Rossi CR, Santinami M et al (2006) Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis. In Vivo 20:739–742
Hayes AJ, Neuhaus SJ, Clark MA, Thomas JM (2007) Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma. Ann Surg Oncol 14:230–238
Eggermont AM, Schraffordt Koops H, Klausner JM et al (1996) Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg 224:756–764
Noorda EM, Vrouenraets BC, Nieweg OE et al (2003) Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities. Cancer 98:1483–1490
Gutman M, Inbar M, Lev-Shlush D et al (1997) High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation. Cancer 79:1129–1137
Cherix S, Speiser M, Matter M et al (2008) Isolated limb perfusion with tumor necrosis factor and melphalan for non-resectable soft tissue sarcomas: long-term results on efficacy and limb salvage in a selected group of patients. J Surg Oncol 98:148–155
Hess LM, Benham-Hutchins M, Herzog TJ et al (2007) A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer. Int J Gynecol Cancer 17:561–570
Noma J, Yoshida N (2008) Intraperitoneal chemotherapy for ovarian cancer. Gan To Kagaku Ryoho 35:885–890
Xu DZ, Zhan YQ, Sun XW et al (2004) Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 10):2727–2730
Moran B, Baratti D, Yan TD et al (2008) Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 98:277–282
Deraco M, Bartlett D, Kusamura S, Baratti D (2008) Consensus statement on peritoneal mesothelioma. J Surg Oncol 98:268–272
Esquivel J, Elias D, Baratti D et al (2008) Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 98:263–267
Helm CW, Bristow RE, Kusamura S et al (2008) Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J Surg Oncol 98:283–290
Bozzetti F, Yu W, Baratti D et al (2008) Locoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol 98:273–276
Mir LM, Orlowski S (1999) Mechanisms of electrochemotherapy. Adv Drug Del Rev 35:107–118
Marty M, Sersa G, Garbay JR et al (2006) Electrochemotherapy—An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE study. EJC[Suppl] 4:3–13
Campana LG, Mocellin S, Basso M et al (2009) Bleomycin-based electrochemotherapy: clinical outcome from a single institution’s experience with 52 patients. Ann Surg Oncol 16:191–199
Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236
Brunello F, Veltri A, Carucci P et al (2008) Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial. Scand J Gastroenterol 43:727–735
Veltri A, Moretto P, Doriguzzi A et al (2006) Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16:661–669
Veltri A, Sacchetto P, Tosetti I et al (2008) Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival. Cardiovasc Intervent Radiol 31:948–956
Lencioni R, Crocetti L, Cioni R et al (2008) Response to radiofrequency ablation of pulmonary tumors: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9:621–628
Veltri A, Garetto I, Pagano E et al (2009) Percutaneous RF thermal ablation of renal tumors: is US guidance really less favorable than other imaging guidance techniques? Cardiovasc Intervent Radiol 32:76–85
Veltri A, Calvo A, Tosetti I et al (2006) Experiences in US-guided percutaneous radiofrequency ablation of 44 renal tumors in 31 patients: analysis of predictors for complications and technical success. Cardiovasc Intervent Radiol 29:811–818
Goetz MP, Callstrom MR, Charboneau JW et al (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22:300–306
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Italia
About this chapter
Cite this chapter
Rossi, C.R., Comandone, A., Veltri, A. (2011). Terapie locoregionali e chirurgia oncologica. In: Nuove tecnologie chirurgiche in oncologia. Springer, Milano. https://doi.org/10.1007/978-88-470-2385-7_11
Download citation
DOI: https://doi.org/10.1007/978-88-470-2385-7_11
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2384-0
Online ISBN: 978-88-470-2385-7
eBook Packages: MedicineMedicine (R0)